drugset / Trial / NCT01519635

Effect of Aliskiren and Hydrochlorothiazide on Kidney Oxygenation in Patients With Hypertension

NCT01519635

Phase 4 Completed 24 enrolled Centre Hospitalier Universitaire Vaudois
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this project is to evaluate the chronic effect (8 weeks) of RASILEZ 300mg (aliskiren) on renal tissue oxygenation in patients with stage 1-2 hypertension, and to compare the chronic effect (8 weeks) of RASILEZ 300mg (aliskiren) on renal tissue oxygenation in patients with stage 1-2 hypertension with these effects with those of ESIDREX 25mg (hydrochlorothiazide).

Timeline

Start
2011-10
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aliskiren Small molecule 300 mg
Comparator Hydrochlorothiazide Unknown 25 mg

Indications